Intrinsic Value of S&P & Nasdaq Contact Us

Proto Labs, Inc. PRLB NYSE

NYSE • Industrials • Manufacturing - Metal Fabrication • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$118.76
+91.8%
Analyst Price Target
$38.50
-37.8%

Proto Labs, Inc. (PRLB) is a Manufacturing - Metal Fabrication company in the Industrials sector, currently trading at $61.91. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of PRLB = $118.76 (+91.8% from the current price, the stock appears undervalued). Analyst consensus target is PRLB = $39 (-37.8% upside).

Valuation: PRLB trades at a trailing Price-to-Earnings (P/E) of 67.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 7.28.

Financials: revenue is $533M, +3%/yr average growth. Net income is $21M, growing at +47%/yr. Net profit margin is 4% (thin). Gross margin is 44.5% (+0.4 pp trend).

Balance sheet: total debt is $5M against $671M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.49 (strong liquidity). Debt-to-assets is 0.6%. Total assets: $760M.

Analyst outlook: 5 / 17 analysts rate PRLB as buy (29%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 19/100 (Fail), Growth 73/100 (Pass), Past 75/100 (Partial), Health 100/100 (Pass), Moat 59/100 (Partial), Future 16/100 (Fail), Income 30/100 (Fail).

$38.50
▼ 37.81% Downside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for Proto Labs, Inc., the average price target is $38.50, with a high forecast of $44.00, and a low forecast of $34.00.
Highest Price Target
$44.00
Average Price Target
$38.50
Lowest Price Target
$34.00

PRLB SharesGrow Score Overview

53/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 19/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 59/100
Gross margin is + market cap
FUTURE 16/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PRLB

VALUE Fail
19/100
PRLB trades at a trailing Price-to-Earnings (P/E) of 67.9 (S&P 500 average ~25). Forward PEG 7.28 — overvalued. Trailing PEG 1.56. Analyst consensus target is $39, implying -37% from the current price $62. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
73/100
PRLB: +3%/yr revenue is, +47%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
PRLB: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet PRLB: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 3.49 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
59/100
PRLB: Gross margin is 44.5% (+0.4 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 59/100. ≥ 70 = Pass.
View details →
FUTURE Fail
16/100
Analyst outlook: 5 / 17 analysts rate PRLB as buy (29%). Analyst consensus target is $39 (-37% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
PRLB: Net profit margin is 4%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range29.59-68.91
Volume141.49K
Avg Volume (30D)187.19K
Market Cap$1.47B
Beta (1Y)1.31
Share Statistics
EPS (TTM)0.89
Shares Outstanding$23.92M
IPO Date2012-02-24
Employees2,357
CEOSuresh Krishna
Financial Highlights & Ratios
Revenue (TTM)$533.13M
Gross Profit$237.14M
EBITDA$64.88M
Net Income$21.24M
Operating Income$26.2M
Total Cash$128.12M
Total Debt$4.65M
Net Debt$-106.17M
Total Assets$760.36M
Price / Earnings (P/E)69.6
Price / Sales (P/S)2.76
Analyst Forecast
1Y Price Target$37.50
Target High$44.00
Target Low$34.00
Upside-39.4%
Rating ConsensusHold
Analysts Covering17
Buy 29% Hold 71% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS7437131094

Price Chart

PRLB
Proto Labs, Inc.  ·  NYSE
Industrials • Manufacturing - Metal Fabrication
29.59 52WK RANGE 68.91
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message